• Locate a Specialist

    Locate a Specialist

    ASCIA is the peak professional body
    of clinical immunology and allergy
    in Australia and New Zealand
    Search here
  • Anaphylaxis Resources

    Anaphylaxis Resources

    ASCIA is the peak professional body
    of clinical immunology and allergy
    in Australia and New Zealand
    Learn more
  • Immunodeficiency

    Immunodeficiency

    ASCIA is the peak professional body
    of clinical immunology and allergy
    in Australia and New Zealand
    Go to information
  • AIFA support research

    AIFA 100% Research

    All donations to AIFA go
    directly to clinical immunology
    and allergy research
    Donate now

ASCIA News

  • AusPollen partnership impact case study published by NHMRC
    An Impact Case Study on the AusPollen Partnership and associated research projects has recently been published by the NHMRC, the peak national body supporting health and medical research in Australia. Read more here The AusPollen partnership is an important research...
  • New ASCIA Management Plan for Delayed Allergic Reactions to Foods
    A new ASCIA Management Plan for Delayed Allergic Reactions to Foods has been developed by the ASCIA Dietitians committee, in response to demand from childrens' education/care services. This plan is to be used for delayed non-IgE mediated allergic reactions to foods: Food Protein...
  • ASCIA 2023 Conference Report
    Thank you to everyone involved in the ASCIA 2023 Conference, which was a highly successful hybrid event, with a record high number of delegates (724 – 72% in-person, 28% virtual), abstracts (165) and social functions. ASCIA 2023 Conference sessions can now be viewed on...
  • Registration is now open for the ASCIA Food Allergy Course for Dietitians in Sydney 23rd-24th November 2023
    Registration is now open for the  ASCIA Food Allergy Course, which has an interactive in-person program that is focussed on medical nutrition therapy in food allergy and intolerance. The course is being held for the first time in Sydney, on Thursday 23rd and Friday 24th...
  • New Subcutaneous Immunoglobulin (SCIg) products
    The National Blood Authority (NBA) has agreed arrangements with Grifols Australia Pty Ltd for the introduction of their Subcutaneous Immunoglobulin (SCIg) product, Xembify 20%, under the national blood arrangements. Supply to the Australian market is anticipated to...
  • Australian Quality Standard for Rheumatoid Arthritis
    The Australian Rheumatology Association (ARA), in collaboration with Arthritis Australia, is developing a Quality Standard for Rheumatoid Arthritis (RA), to improve the quality of care for people living with RA. The final quality statements will be based on consensus...
  • ASCIA Survey to improve undergraduate allergy education for health professionals
    ASCIA is conducting a short survey to help improve undergraduate allergy education for future health professionals, as part of the National Allergy Council (NAC) Shared Care for Allergy (SCA) Project.  The survey is open until 21 August 2023 at ASCIA Allergy Training Survey   ...
  • Transition from Evogam to Hizentra AU SCIg products
    In May 2022, the National Blood Authority (NBA) announced that five domestically produced plasma products are undergoing transition in 2023 and 2024. From 2 August 2023, patients on EVOGAM subcutaneous immunoglobulin (SCIg) product will transition to HIZENTRA AU, if they...
More ASCIA News
ASCIA Member Login
Site last updated: 15 Sep 2023
 

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

ASCIA welcomes your feedback.

Feedback
About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia

Back to top